Key Takeaways
- • Third Point declined 50 basis points in November, bringing year-to-date performance to 7.9 percent—significantly trailing the S&P 500's 16.5 percent gain in 2025, positioning the multistrategy fund likely to underperform the broader market for the full year.
- • Nvidia, Amazon, Microsoft, and Taiwan Semiconductor Manufacturing Company were the fund's four largest losers in November, with Microsoft falling 5 percent despite becoming Third Point's largest equity long position heading into December.
- • Kenvue emerged as November's biggest winner with a 21 percent monthly surge, though it remains the fund's largest year-to-date loser following Trump administration statements linking Tylenol use during pregnancy to autism.
- • Third Point's equity book net long exposure increased 10 percentage points to just over 70 percent of the portfolio, while credit comprises 33 percent of net exposure and privates and other strategies account for nearly 8 percent, bringing total portfolio net exposure to approximately 113 percent.
- • Nvidia and TSMC retained positions among the fund's top five year-to-date winners despite November losses, while the top-five holdings remain Microsoft, Kenvue, Nvidia, Pacific Gas & Electric, and Amazon.
Summary
Third Point, the multistrategy hedge fund led by Dan Loeb, posted a modest loss in November as significant exposure to Magnificent Seven technology stocks weighed on performance. The fund declined 50 basis points during the month, reducing its year-to-date return to 7.9 percent—less than half the S&P 500's 16.5 percent return for 2025. This performance trajectory suggests Third Point will likely trail the broader market for the full year, presenting a notable headwind for institutional investors evaluating the fund's positioning relative to passive indices.
The November underperformance was directly attributable to weakness in the fund's concentrated positions within mega-cap technology names. Nvidia, Amazon, Microsoft, and Taiwan Semiconductor Manufacturing Company comprised four of Third Point's five largest monthly losers. Microsoft, which moved to become the fund's largest equity long position entering December, fell 5 percent during November. Notably, despite these November setbacks, both Nvidia and TSMC remained among the fund's five best performers year-to-date, underscoring the volatility inherent in heavy technology exposure.
The fund's portfolio construction reveals meaningful leverage and concentrated bets. The equity book's net long exposure stands just above 70 percent, having increased by 10 percentage points in November. Credit strategies represent 33 percent of net exposure, while privates and other strategies account for approximately 8 percent, resulting in total portfolio net exposure of roughly 113 percent. This leverage profile amplifies both upside and downside moves in the equity components.
Kenvue, the consumer health care spinoff from Johnson & Johnson, demonstrated exceptional volatility in Third Point's portfolio. The stock surged nearly 21 percent in November, making it the fund's largest monthly winner. However, Kenvue remains the fund's biggest loser year-to-date, reflecting the significant headwinds created by Trump administration statements linking prenatal Tylenol use to autism. This dynamic illustrates how regulatory and public health developments can rapidly reverse trading thesis attractiveness. Third Point's top-five holdings entering December—Microsoft, Kenvue, Nvidia, Pacific Gas & Electric, and Amazon—showed reordered positioning relative to October, with only the composition remaining consistent.
The November underperformance was directly attributable to weakness in the fund's concentrated positions within mega-cap technology names. Nvidia, Amazon, Microsoft, and Taiwan Semiconductor Manufacturing Company comprised four of Third Point's five largest monthly losers. Microsoft, which moved to become the fund's largest equity long position entering December, fell 5 percent during November. Notably, despite these November setbacks, both Nvidia and TSMC remained among the fund's five best performers year-to-date, underscoring the volatility inherent in heavy technology exposure.
The fund's portfolio construction reveals meaningful leverage and concentrated bets. The equity book's net long exposure stands just above 70 percent, having increased by 10 percentage points in November. Credit strategies represent 33 percent of net exposure, while privates and other strategies account for approximately 8 percent, resulting in total portfolio net exposure of roughly 113 percent. This leverage profile amplifies both upside and downside moves in the equity components.
Kenvue, the consumer health care spinoff from Johnson & Johnson, demonstrated exceptional volatility in Third Point's portfolio. The stock surged nearly 21 percent in November, making it the fund's largest monthly winner. However, Kenvue remains the fund's biggest loser year-to-date, reflecting the significant headwinds created by Trump administration statements linking prenatal Tylenol use to autism. This dynamic illustrates how regulatory and public health developments can rapidly reverse trading thesis attractiveness. Third Point's top-five holdings entering December—Microsoft, Kenvue, Nvidia, Pacific Gas & Electric, and Amazon—showed reordered positioning relative to October, with only the composition remaining consistent.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.